Thermo Fisher Scientific (TMO) Restructuring Costs (2009 - 2026)

Thermo Fisher Scientific has disclosed Restructuring Costs across 18 years of filings, most recently posting $49.0 million for Q1 2026.

• Quarterly Restructuring Costs fell 50.0% year-over-year to $49.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $312.0 million (down 30.36% YoY) and the FY2025 annual result came in at $70.0 million, up 40.0% from the prior year.
• Restructuring Costs grew to $49.0 million in Q1 2026, from $46.0 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $228.0 million in Q4 2024 and troughed at $2.0 million in Q2 2022.
• A 5-year average of $80.1 million and a median of $77.0 million in 2024 frame the typical range for Restructuring Costs.
• Annual changes were most pronounced in 2022 — Restructuring Costs sank 85.71% — and 2023, when it soared 5500.0%.
• Tracing TMO's Restructuring Costs over 5 years: stood at $55.0 million in 2022, then soared by 45.45% to $80.0 million in 2023, then soared by 185.0% to $228.0 million in 2024, then sank by 79.82% to $46.0 million in 2025, then climbed by 6.52% to $49.0 million in 2026.
• Business Quant data shows TMO's Restructuring Costs at $49.0 million in Q1 2026, $46.0 million in Q4 2025, and $135.0 million in Q3 2025.